Recruiting NCT06005766
This summary needs review. Please check the official study record and contact the research team for details.
In Vaasa Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Depression Behavioral Over 18 Years
Countries Finland
Sponsor University of Jyvaskyla
Condition Schizophrenia, Depression Not Yet Recruiting NCT07593456
This study is not yet recruiting in the United States. It focuses on Schizophrenia.
Multiple locations, including Glen Oaks Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 65 Years
Countries United States
Sponsor North Shore Therapeutics, Inc.
Condition Schizophrenia Recruiting NCT06650943
This summary needs review. Please check the official study record and contact the research team for details.
In Bilbao Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral
Countries Spain
Sponsor Hospital de Basurto
Condition Schizophrenia Not Yet Recruiting NCT07387705
This study is not yet recruiting. It focuses on Schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Other
Countries
Sponsor University of Illinois at Chicago
Condition Schizophrenia Completed NCT00650611
This study is completed in the United States. It is testing ziprasidone for Schizophrenia.
Multiple locations, including San Diego Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Bipolarity Drug i A study involving a medication or substance. From 10 Years to 17 Years
Countries United States
Sponsor Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition Schizophrenia, Bipolarity Terminated NCT03669640
This study was terminated in the United States, in Japan, in Spain, .... It is testing Effects of RO6889450 (Ralmitaront) for schizophrenia.
Multiple locations, including Bellflower Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 55 Years
Countries United States, Japan, Spain, ...
Sponsor Hoffmann-La Roche
Condition Schizophrenia Withdrawn NCT06878833
This study was withdrawn. It is testing Long-Acting Oral Risperidone for schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries
Sponsor Lyndra Inc.
Condition Schizophrenia Completed NCT04512066
This study is completed in the United States, in Japan, in Russia, .... It focuses on schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 45 Years
Countries United States, Japan, Russia, ...
Sponsor Hoffmann-La Roche
Condition Schizophrenia Completed NCT01101464
This study is completed. It focuses on schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries
Sponsor Organon and Co
Condition Schizophrenia Completed NCT00306475
This study is completed in the United States. It focuses on schizophrenia.
In Nashville Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 65 Years
Countries United States
Sponsor Northwestern University
Condition Schizophrenia Completed NCT00373672
This summary needs review. Please check the official study record and contact the research team for details.
In Nashville Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 65 Years
Countries United States
Sponsor Northwestern University
Condition Schizophrenia Completed NCT00212784
This study is completed. It is testing asenapine Using an Active Control for schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries
Sponsor Organon and Co
Condition Schizophrenia